SCHAUMBURG, Ill., March 19, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its Board of Directors has appointed James M. Hussey as its President, effective March 25, 2013. Mr. Hussey, 53, will be responsible for Sagent's commercial operations, including development, regulatory and supply chain activities, as well as having primary responsibility over the Company's sales, marketing and human resources functions.
"We are delighted to have Jim join the organization as our president," said Jeffrey M. Yordon, chief executive officer and chairman of the board of Sagent. "Given the growth trajectory we have experienced and our projected performance going forward, we want to provide seasoned leadership to our commercial operations while I continue to drive strategic development, develop partner relationships and investigate vertical integration. Jim has significant industry experience and knowledge of specialty pharmaceuticals and is a great addition to our leadership team. We look forward to his contributions as we move forward."
Mr. Hussey stated, "I'm pleased to be joining the Sagent team, which has established a track record of success in the injectable pharmaceuticals market using a unique business model. I look forward to playing an instrumental role in executing our strategic objectives to drive future growth and long-term profitability."Hussey has over 25 years of experience in the pharmaceutical and healthcare industries with experience in both large Pharma and emerging start-ups, most recently with NanoInk, a privately held Nanolithography company, where he served as chief executive officer and Ovation Pharmaceuticals, a privately held pharmaceutical company, where he served as vice president of strategic planning. Prior to his career with Ovation, Hussey worked for NeoPharm, Inc., Physician Quality Care, Inc. and Bristol Myers Squibb Company. In addition, Hussey has extensive board experience with start-up companies and community organizations. He earned a Bachelor's degree in Pharmacy from Butler University and an MBA from the University of Illinois at Chicago.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV